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Glutathione peroxidases are widespread among eukaryotic organisms and function as a major defense
against hydrogen peroxide and organic peroxides. However, glutathione peroxidases are not well studied
among prokaryotic organisms and have not previously been shown to promote bacterial virulence. Recently, a
gene with homology to glutathione peroxidase was shown to contribute to the antioxidant defenses of Strepto-
coccus pyogenes (group A streptococcus). Since this bacterium causes numerous suppurative diseases that
require it to thrive in highly inflamed tissue, it was of interest to determine if glutathione peroxidase is
important for virulence. In this study, we report that GpoA glutathione peroxidase is the major glutathione
peroxidase in S. pyogenes and is essential for S. pyogenes pathogenesis in several murine models that mimic
different aspects of streptococcal suppurative disease. In contrast, glutathione peroxidase is not essential for
virulence in a zebrafish model of streptococcal myositis, a disease characterized by the absence of an inflam-
matory cell infiltrate. Taken together, these data suggest that S. pyogenes requires glutathione peroxidase to
adapt to oxidative stress that accompanies an inflammatory response, and the data provide the first demon-
stration of a role for glutathione peroxidase in bacterial virulence. The fact that genes encoding putative
glutathione peroxidases are found in the genomes of many pathogenic bacterial species suggests that gluta-
thione peroxidase may have a general role in bacterial pathogenesis.
The generation and release of toxic reactive oxygen species
by phagocytic cells is thought to be an important component of
the host’s immunity against bacterial infections. In response,
successful pathogens have evolved effective systems for de-
fense against oxidative stress that include combinations of re-
ducing enzymes, molecular scavengers, and protein and DNA
repair enzymes (for reviews, see references 11 and 23). Not
surprisingly, mutants defective for resistance to oxidative stress
are often avirulent in animal models of infection (8, 17, 21, 32).
For some bacteria, the mechanisms used to defend them-
selves from oxidative stress and the possible contribution that
these defense pathways may make to virulence is much less
clear. For example, as a member of the lactic acid family of
bacteria, Streptococcus pyogenes (group A streptococcus) does
not produce heme and therefore lacks many of the reducing
enzymes required for resistance to oxidative stress in other
bacterial species (5). Despite this apparent deficiency, this
gram-positive bacterium causes numerous suppurative diseases
that require it to thrive in the presence of the oxidative stresses
caused by the intense inflammatory response that is character-
istic of streptococcal infection (7). In addition, hydrogen per-
oxide is a by-product of the fermentative metabolism of S.
pyogenes, and the bacterium can survive the millimolar con-
centrations of peroxide it can produce endogenously (14).
These observations have suggested that S. pyogenes must have
a robust ability to defend itself from oxidative stress.
A previous study used a functional genomics approach to
identify possible nonheme oxoreductases that could contribute
to the oxidative defenses of S. pyogenes (18). One of the genes
examined encoded a putative protein with homology to gluta-
thione (GSH) peroxidase (GpoA) (genomic locus Spy0605;
GenBank accession no. AE006515), a selenoprotein oxoreduc-
tase that has been well studied in eukaryotic cells and that
plays important roles in the protection of cells against oxida-
tion of DNA and maintenance of cellular redox balance (2).
GSH peroxidase activity has been studied previously for only
one prokaryote, Neisseria meningitidis (24, 25). Inactivation of
the gene for GpoA in N. meningitidis increases the sensitivity of
the resulting mutants to oxidative stress induced by the redox-
cycling agent paraquat (methyl viologen) (24). A similar phe-
notype has also been observed in eukaryotic cells depleted of
GSH peroxidase activity (2). Examination of the plethora of
recently completed prokaryotic genome sequences, including
those of Staphylococcus aureus, Bacillus subtilis, Lactococcus
lactis, Listeria monocytogenes, Pseudomonas aeruginosa, Clos-
tridium acetobutylicum, Caulobacter crescentus, Salmonella en-
terica, and Yersinia pestis, has revealed the presence of genes
with homology to GSH peroxidase (K. King and M. Caparon,
unpublished data). This broad distribution among diverse bac-
terial species suggests that GSH peroxidase also makes an
important contribution to stress resistance in prokaryotes and
contributes to bacterial virulence. However, its importance to
virulence remains to be established.
In S. pyogenes, GpoA mutants are aerotolerant and grow at
rates identical to that of the wild type under aerobic and
anaerobic conditions (18). However, the mutants do demon-
strate the characteristic enhanced sensitivity to paraquat ob-
served in N. meningitidis and eukaryotic cells (18), suggesting
that GpoA does contribute to stress resistance. In addition, S.
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pyogenes contains a gene with homology to the gene encoding
glutathione reductase (GSSG reductase) (genomic locus
Spy0813; GenBank accession no. AE006532) and is one of the
few streptococcal species that accumulates significant amounts
of GSH (29). Taken together, these data suggest that GSH and
GSH peroxidase are important for stress resistance and viru-
lence of S. pyogenes.
In the present study, we examined the ability of GpoA-
deficient S. pyogenes to cause disease in several different ani-
mal models of infection. The data indicate that the GpoA GSH
peroxidase is the major GSH peroxidase in S. pyogenes and
makes a significant contribution to the severity of disease in
those infections that are characterized by high levels of inflam-
mation. This study provides the first direct demonstration of a
role for GSH peroxidase in bacterial pathogenesis.
MATERIALS AND METHODS
Strains, media, and growth conditions. The construction of a mutant (G8.7)
containing an in-frame deletion mutation of gpoA in a wild-type S. pyogenes
background (HSC5) (16) was performed as described in a previous study (18).
Routine culture utilized Todd-Hewitt broth (BBL) supplemented with 0.2%
yeast extract (Difco) (THY medium). Culturing of streptococci for infection of
animals followed established protocols, including growth in THY for infection of
mice and zebrafish (26). For determination of the number of CFU, appropriate
dilutions of cultures were prepared in saline and plated on solid THY medium
containing Bacto agar (Difco) at a final concentration of 1.4%. Incubation of all
bacterial cultures was conducted at 37°C, and cultures on solid media were
incubated under the anaerobic conditions produced using a commercial gas
generator (GasPack, catalogue no. 70304; BBL).
Determination of GSH peroxidase activity. Wild-type and GpoA S. pyogenes
were grown with agitation in THY medium for 16 h at 37°C. The cells were
washed twice with 20 mM Tris-HCl buffer, pH 8.2, and a soluble protein extract
was prepared by breaking the cells using sonication followed by centrifugation at
27,200  g for 15 min at 4°C to collect the supernatant fluids. To measure GSH
peroxidase activity, a coupled spectrophotometric assay was utilized in which
NADPH oxidation by GSSG reductase was monitored at 340 nm (ε  6.2 mM1
cm1). Reaction mixtures initially contained the followings: 10 mM Na phos-
phate buffer (pH 7.0), 1 mM diethylenetriaminepentaacetic acid, 250 M
NADPH, 2 mM GSH, and 0.5 U of GSSG reductase in a final volume of 1 ml.
The reaction mixture was equilibrated at 25°C for 5 min, and the background rate
of NADPH oxidation was determined following the addition of soluble protein
extract containing up to 6 g of total soluble protein. For calculation of GSH
peroxidase activity, H2O2 was added to a final concentration of 50 M and the
rate of NADPH oxidation was measured. Activity reported was calculated by
subtracting the background rate from the rate in the presence of H2O2. To
confirm the accuracy of the assay, known concentrations of bovine erythrocyte
GSH peroxidase (Sigma) were added to selected reactions, and in all cases the
rate increased by the amount expected based on the amount of bovine GSH
peroxidase added. To confirm that observed NADPH oxidation reflected GSH
peroxidase and not NADPH-dependent alkylhydroperoxidase, the entire set of
experiments was repeated leaving out GSH, GSSG reductase, or both, and
NADPH oxidation was found to be negligible.
Murine subcutaneous infection model. The method of Bunce et al. (4) as
modified by others (20, 28) was used to establish an infection of S. pyogenes in the
subcutaneous tissue of mice. Briefly, streptococcal strains were prepared for
injection into mice by culturing them in 40 ml of THY medium to the mid-
logarithmic phase of growth (optical density at 600 nm  0.300). Bacteria were
collected by centrifugation, washed once with 10 ml of sterile saline, and resus-
pended in 1 ml of sterile saline. To disrupt streptococcal chains, this suspension
was subjected to brief sonication (four pulses of 10 s each), using a cup horn
probe with the sonic disruptor (Branson Model 185) at a power setting of 8. The
number of CFU in the suspension was determined as described above. For
infection of soft tissue, 6- to 8-week-old female SKH1 hairless mice (Charles
River Labs), commonly used in the subcutaneous model of S. pyogenes infection,
received subcutaneous injections into the left flank of 107 CFU in a 100-l
volume that was delivered using a 1-ml insulin syringe (Becton-Dickinson).
Control mice were injected with saline alone, and each study group consisted of
10 mice that were housed together. Mice were observed and weighed daily, and
the appearance of the cutaneous tissue at the site of injection was documented
every 24 h by digital photography. Any visible ulceration, as defined by the loss
of the overlaying stratum corneum and epidermis, was analyzed from the pho-
torecord using MetaMorph image analysis software (version 4.6; Universal Im-
aging Corp.) to precisely determine the area contained by the irregular border of
each ulcer. Data presented were representative of three independent experi-
ments.
Intraperitoneal infection of mice. A lethal systemic infection of mice was
established by intraperitoneal injection of S. pyogenes as follows: streptococcal
strains were cultured and prepared as described above for infection of the
subcutaneous tissues. A dose of 108 CFU in a volume of 100 l was injected into
4- to 6-week-old C57BL/6J mice (Jackson Laboratories) at a location approxi-
mately 0.5 cm to the left of the midline at the lower abdomen. This species of
mice is susceptible to lethal infection by S. pyogenes, and its immune system is
well characterized. A control group of mice received an injection of sterile saline
alone. Mice were housed in groups of five with free access to food and water
throughout the entire experiment. Infected mice were observed daily for a period
of 9 days. Data presented are representative of two independent experiments,
each conducted with 10 mice per experimental group, and each with similar
results.
Infection of zebrafish. Intramuscular infection of zebrafish was conducted as
previously described (26) with the addition of a brief sonication to disrupt
streptococcal chains as described above. Each zebrafish was injected in the dorsal
muscle with 106 CFU in a volume of 10 l. Following infection, zebrafish were
monitored daily for a period of 5 days. Each experimental group consisted of at
least 16 zebrafish, and a mock-infected control group was included in each
experiment which consisted of a group of eight zebrafish injected with sterile
medium alone. Data presented are representative of at least two independent
experiments.
Analysis of bacteria in infected tissues. To determine the number of CFU in
cutaneous tissue, a tissue block was removed from infected animals that included
the skin surrounding the lesion, the underlying adipose tissue, and muscle. The
tissue block was mixed with 1 ml of saline solution and homogenized using a
motorized homogenizer (PCR Homogenizer; Cole-Parmer Instrument Co.), and
the number of CFU determined as described above. The number of viable
bacteria present in the peritoneal cavity was sampled by washing the peritoneal
cavity with 5 ml of ice-cold saline according to the method of Dunn et al. (10).
Aseptic removal of the spleen, followed by homogenization and plating as de-
scribed above, was done to determine the number of CFU in the spleens of
infected mice.
Statistical analyses. Kaplan-Meier product limit estimates of survival curves
were used to compare infection by wild-type and mutant streptococci, and dif-
ferences were tested for significance by the log rank test (15). The difference
between the numbers of mice developing an ulcer following subcutaneous chal-
lenge with wild-type bacteria and with mutant bacteria was tested for significance
by the Chi-square test with Yates’ correction (15), and differences in the areas of
the resulting ulcers were tested by the Mann-Whitney U test (15). For all test
statistics, the null hypothesis was rejected when P values were 0.05.
RESULTS
GpoA mutants are deficient in GSH peroxidase activity.
Prior examination of the genome of S. pyogenes revealed a
gene (gpoA) that is highly homologous to a family of genes that
encode GSH peroxidases (18). Consistent with a function as a
peroxidase, mutation of gpoA was associated with an increased
sensitivity to peroxide stress (18). However, it has not been
shown that S. pyogenes has the capacity to express GSH per-
oxidase activity and that this activity is missing in GpoA
mutants. Upon analysis, it was found that the wild-type strain
expressed a GSH peroxidase activity corresponding to 1.32 
0.22 nmol of NADPH oxidized min1 g of total soluble pro-
tein1 (n  12). This level of activity is approximately fivefold
higher than the GSH peroxidase activity expressed by a human
endothelial cell line (12). In contrast, it was not possible to
detect GSH peroxidase activity in the GpoA mutant of S.
pyogenes at any rate consistently higher than background (n 
24). Taken together, these data indicate that S. pyogenes can
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express a robust GSH peroxidase activity and that this activity
is negligible in a GpoA mutant.
Mutants deficient in GpoA are attenuated in a murine
model of subcutaneous infection. Once it was established that
the GpoA mutant lacked GSH peroxidase activity, it was of
interest to determine the contribution of GpoA to streptococ-
cal pathogenesis. The range of different infections that can be
caused by S. pyogenes is extensive and includes both suppura-
tive and nonsuppurative diseases (7). As a consequence, no
one animal model can accurately represent the features of all
S. pyogenes diseases. For example, the suppurative diseases
range from localized infections of the soft tissues of the phar-
ynx and skin (pharyngitis, impetigo), to involvement of the
deeper cutaneous tissues (erysipelas, cellulitis) to highly de-
structive infections characterized by extensive necrosis (necro-
tizing fasciitis, myositis) (7). Thus, to most thoroughly examine
the role of GSH peroxidase in streptococcal pathogenesis, the
behavior of GpoA mutants was evaluated in animal models
that reproduce different elements of a number of streptococcal
diseases. The initial studies utilized the murine subcutaneous
infection model (4, 20, 28), which produces a highly inflamma-
tory localized lesion in soft tissue characterized by extensive
recruitment of inflammatory cells to the site of bacterial pro-
liferation (4, 28).
The wild-type S. pyogenes strain HSC5 and an isogenic mu-
tant (G8.7) containing an in-frame deletion mutation in GpoA
(18) were used to infect SKH1 hairless mice. At a dose of 107
CFU, the wild-type strain typically produces a well-defined
area of induration by between 8 to 12 h postinfection that is
characterized by the recruitment of large numbers of inflam-
matory cells, of which the majority are neutrophils (data not
shown). By 18 to 24 h, the region of induration ulcerates and
develops an eschar followed by the gradual expansion of the
margins of the ulcer to reach a maximum area by about day 3
(data not shown). Beginning around day 8 the lesion begins to
resolve, and by day 14 it is typically healed. The streptococci
remain localized to the lesion, and only low numbers of bac-
teria (10 CFU/g of tissue) can be recovered from the spleen
at any time point.
When the mutant and the wild type were compared at the
point when lesions typically first appear, very few mice infected
by the GpoA mutant had developed lesions (day 1, Fig. 1), and
the few mice that had developed lesions showed small lesions.
Over the course of the infection, mice infected by the GpoA
mutant developed significantly smaller ulcerations than mice
infected by the wild-type strain (Fig. 1, day 3).
GpoA mutant bacteria are abundant in infected skin. Most
mice infected with the GpoA mutant showed no symptoms of
infection, including visible induration or ulceration of tissue
and weight loss, by day 1 after infection. However, since mice
infected by the wild-type strain accumulate a large number of
inflammatory cells at the injection site by 8 h after infection,
and ulceration begins to develop about 20 h after infection, it
was of interest to determine if the mutant was attenuated,
because it was rapidly cleared from the tissue by this time
point. To test this, the cutaneous tissue and underlying muscle
at the site of injection was excised from groups of mice at 12
and 20 h and at 3 days after infection. Mice infected with 107
CFU of the wild-type strain demonstrated high numbers of
bacteria in tissue at all time points (Fig. 2). Contrary to expec-
tations, the GpoA mutant was not rapidly cleared from all
mice over the first 20 h of infection and was present in a
recoverable form at a time when the mice infected by the
wild-type strain were beginning to demonstrate extensive tissue
pathology (Fig. 2). In fact, high numbers of GpoA mutant
streptococci could still be recovered from mice at 3 days post-
challenge. These data suggest that the development of pathol-
ogy in cutaneous tissue is not simply dependent on the ability
of the streptococcus to persist in tissue.
GpoA mutants are attenuated in a murine model of sys-
temic infection. Unlike some strains (28, 20), HSC5 does not
produce a systemic infection following its introduction into the
subcutaneous tissues. However, it will produce lethal systemic
disease subsequent to infection of the peritoneal cavity. Thus,
in order to determine the contribution of GSH peroxidase to
the pathogenesis of systemic disease, the abilities of the wild
type and mutant to cause death following intraperitoneal chal-
lenge were compared. At a dose of 108 CFU, 100% of mice
injected with the wild-type strain were dead 4 days after chal-
lenge (Fig. 3). At that same time point a majority of the mice
injected with the GpoA mutant survived. Additional mortal-
ity was observed in the group infected by the GpoA mutant
over the next several days. Overall, the time to death was
FIG. 1. Skin lesion development in mice following subcutaneous
infection. Groups of at least 10 female SKHI hairless mice received a
subcutaneous injection of 107 CFU of wild-type or GpoA mutant
streptococci and were observed after 1 and 3 days (top and bottom
panels, respectively) for the development of a visible ulcer, whose area
was determined as described in Materials and Methods. At the time of
maximal lesion development for the wild-type strain (3 days), the
wild-type strain produced a significantly more severe disease in that the
areas of the resulting ulcers were significantly larger (P  0.01). Each
symbol represents the area of ulcer observed in an individual mouse,
and the horizontal bar indicates the mean value obtained for each
group of 10 mice.
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significantly reduced for animals infected by the GpoA mu-
tant (Fig. 3), indicating that the loss of GSH peroxidase activity
is associated with a reduced ability to cause lethal systemic
infection. Examination of the number of viable streptococci
that could be recovered from the peritoneal cavity over the first
18 h of infection revealed no large difference between wild
type-infected and GpoA mutant-infected mice (Fig. 4). How-
ever, when the numbers of bacteria recovered from the spleen
were evaluated, smaller numbers were consistently observed in
mice infected by the GpoA mutant (Fig. 4). These data sug-
gest that the slower kinetics of death observed with the mutant
may be associated with a reduced ability to disseminate from
the spleen.
GpoA mutants are not attenuated for virulence in a ze-
brafish model of intramuscular infection. Among the most
severe forms of invasive group A streptococcal infection is
myositis, which may have fatality rates as high as 80% (30). In
an experimental baboon model of S. pyogenes myositis, a key
difference between fatal and nonfatal infection was the inten-
sity of the inflammatory response. Surviving animals exhibited
an intense neutrophilic infiltrate at the site of infection, while
nonsurvivors had virtually no influx of neutrophils and exten-
sive bacterial growth in muscle (31). A more tractable model of
myositis has recently been developed using zebrafish (26). In
this model, injection of S. pyogenes into the dorsal muscle of
zebrafish results in a fatal myositis with pathology that closely
represents that of fatal disease in baboons, including a dra-
matic absence of an inflammatory infiltrate (26). This lack of
inflammatory cells produces a tissue environment that con-
trasts with the large numbers of inflammatory cells that are
observed at the site of infection in mouse subcutaneous tissue
(4, 28). In order to determine the contribution of GSH perox-
idase to survival in tissue in the absence of an inflammatory
infiltrate, the wild type and the GpoA mutant were injected
FIG. 2. Persistence of S. pyogenes in skin. Mice were challenged
with wild-type and GpoA mutant S. pyogenes as described for Fig. 1.
At the time points indicated, the skin including underlying adipose
tissue and abdominal muscle was excised at an additional radius ex-
tending at least 2 mm from the margin of induration present at the site
of infection. Each symbol represents the number of CFU of the indi-
cated strain recovered from an individual mouse, and the bar repre-
sents the mean value obtained for each group of mice.
FIG. 3. Survival of mice following intraperitoneal challenge.
Groups of at least 10 C57BL/6 mice were challenged intraperitoneally
with 108 CFU of wild-type or GpoA mutant S. pyogenes. Survival of
mice was monitored daily for 9 days, and the data were presented as a
Kaplan-Meier plot. The data indicate that the wild-type strain was
significantly more lethal than the GpoA mutant (P  0.01).
FIG. 4. Recovery of wild-type and mutant S. pyogenes following
intraperitoneal challenge. Groups of six C57BL/6J mice were chal-
lenged intraperitoneally as described for Fig. 3. At the indicated time
points, the numbers of CFU that could be recovered from the perito-
neal cavity and the spleen were determined (top and bottom panels,
respectively). Each symbol represents the number of CFU of the in-
dicated strain recovered from an individual mouse, and the bar rep-
resents the mean value obtained for each group of six mice.
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into zebrafish muscle at a dose of 106 CFU and survival was
observed for 5 days. While all fish that had received an injec-
tion of sterile medium alone survived, there was no significant
difference in the rate of death between fish challenged with the
wild-type or with GpoA mutant bacteria (Fig. 5).
DISCUSSION
These data provide the first direct evidence that GSH per-
oxidase makes a contribution to bacterial pathogenesis. Con-
sistent with a role in defense against oxidative stress, GpoA
was important in those infections that required S. pyogenes to
interact with host cells in an inflammatory exudate. These data,
combined with the distribution of genes with homology to
GpoA in other pathogenic bacterial species, suggests that GSH
peroxidase may have a general role in bacterial virulence.
The specific contribution of GpoA to S. pyogenes virulence
appears to be complex. While a previous study found that the
GpoA mutant was more sensitive to the oxidative stress gen-
erated by paraquat, the mutant grew normally under aerobic
conditions and was not more sensitive to hydrogen peroxide
(18). Furthermore, the wild type and the GpoA mutant could
both be induced to high-level peroxide resistance by a prior
exposure to a sublethal dose of peroxide (18). These data
suggest that S. pyogenes has a complex defense against oxida-
tive stress that involves several overlapping antioxidant sys-
tems. This same phenomenon has been well studied with many
organisms, including Escherichia coli and Salmonella (for a
review, see reference 11), although in the case of S. pyogenes,
the identities of the major antioxidant systems have not been
established (18). However, the fact that GpoA mutants are
attenuated in vivo indicates that the gpoA gene product makes
an essential contribution to stress resistance under highly in-
flammatory conditions.
The unique contribution of GpoA could result from its ex-
clusive expression in a critical host compartment that lacks
cues for expression of other streptococcal antioxidant enzymes.
Alternatively, since GSH peroxidases often have activity
against a broad range of substrates, including hydrogen perox-
ide, organic peroxides, peroxynitrites, and others (1, 2), it is
also possible that GpoA provides protection from a specific
reactive species that it encounters only in vivo and that is not
detoxified by any other antioxidant system. Instead of a unique
reactive species, it could also be the case that the concentration
of one particular toxic species plays a role. For example, E. coli
has several enzymes with an ability to degrade hydrogen per-
oxide, but these demonstrate different kinetic efficiencies (6).
It has been suggested that the importance of any one enzyme
to peroxide homeostasis is linked to the concentration of per-
oxide the organism encounters (6). In this model, an enzyme
like catalase is important at high peroxide concentrations that
saturate a more kinetically efficient scavenger like alkyl hy-
droperoxide reductase, which is the predominant scavenger at
low peroxide concentrations (6).
It is also possible that the effects of the loss of GpoA activity
are due to secondary effects on streptococcal gene regulation
caused by an alteration in the redox balance within the bacte-
rium. For example, the expression of the adhesin protein F is
altered in mutants lacking superoxide dismutase (13). Simi-
larly, eukaryotic GSH peroxidases can alter the redox activa-
tion of transcription factors such as NFB (reviewed in refer-
ence 2). This phenomenon could explain why the attenuation
of the GpoA mutant in subcutaneous infection was not the
result of rapid clearance of the streptococci. In this scenario,
an altered redox balance leads to changes in expression of a
streptococcal gene product that is involved in promoting an
inflammatory response. A precedent for this model has been
established for Yersinia enterocolitica, where mutation of a
gene for a transcription regulator known as RovA attenuates
disease, even though the mutant has a normal ability to pro-
liferate in regional lymph nodes (9). There is a marked lack of
inflammation in lymph nodes during infection produced by the
mutant that correlates with the inability of the mutant to in-
duce interleukin 1 alpha during infection, suggesting that a
RovA-regulated gene product is required to actively induce
inflammation to support pathogenesis (9). Interestingly, RovA
is highly homologous to SlyA, a regulator of oxidative stress
resistance in Salmonella (3).
Mutants defective in various stress response pathways can be
used to probe the host’s response against a pathogen in specific
tissues. For example, while GpoA mutants were abundant in
the subcutaneous tissue during infection, they produced signif-
icantly less damage to tissue than the wild-type strain. This
suggests that GpoA modulates how S. pyogenes adapts to the
host’s response.
Another tissue-specific difference between the wild type and
the mutant was the observation that the GpoA mutant was not
attenuated for infection of zebrafish, despite the fact that te-
leost fish have a complex immune system that resembles that of
mammals (for a review, see references 22 and 27). In fact,
zebrafish granulocytes have a complement of enzymes for the
generation of reactive oxygen species that is similar to that of
mammalian cells (19). Thus, it is unlikely that the lack of
attenuation of the mutant is due to the failure of zebrafish
leukocytes to produce any particular reactive species. Rather,
the virulence of the mutant is likely due to the fact that S.
pyogenes infection of zebrafish muscle is associated with a pro-
found absence of an infiltration of inflammatory cells into the
tissue (26). These data suggest that in the absence of inflam-
FIG. 5. The GpoA mutant is virulent in a zebrafish model of
myositis. Groups of at least 16 zebrafish were challenged intramuscu-
larly with 106 CFU of wild-type and GpoA mutant S. pyogenes. Sur-
vival was monitored over a period of 5 days. Data indicate that there
was no significant difference in virulence between the wild-type and
GpoA mutant strains (P 	 0.1).
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mation GpoA is not required for virulence and that determi-
nants of streptococcal virulence differ according to the tissue
site of infection.
Assessment of the role of other bacterial GSH peroxidases
will provide further knowledge about the importance of this
enzyme for virulence in diverse host environments. Additional
study of GpoA in infection by S. pyogenes should prove valu-
able for further understanding the interplay of host and patho-
gen in the pathogenesis of the diverse diseases that this bac-
terium can cause.
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